Covington & Burling LLP has one of the world's most active and respected Pharmaceutical Litigation and Investigations Practices, with over 110 firm lawyers engaged in this work. Drawing on the expertise of the firm's pre-eminent FDA regulatory practice, our litigators have helped guide some of the world's leading pharmaceutical companies through all aspects of difficult investigations and lawsuits. Covington represents more pharmaceutical companies in more criminal and civil investigations by federal and state government agencies, including high-profile congressional inquiries than any firm in the country. Our litigation experience is broad, encompassing many areas including, suits under the False Claims Act, product liability litigation, patent litigation, pricing and antitrust litigation, litigation with federal agencies, and insurance coverage disputes. We are currently playing a lead role in the Average Wholesale Price litigation; antitrust cases involving Canadian reimportation and authorized generics; Hatch-Waxman patent cases and associated antitrust litigation; nationwide product liability litigation; and various regulatory litigation.
Representative Matters
- Lead counsel to Pfizer on numerous investigations into physician interaction practices and the marketing and promotion of various prescription drugs by the Department of Justice, multiple state Attorneys General, Congress and the Securities and Exchange Commission.
- Lead counsel to GlaxoSmithKline in a Department of Justice investigation into physician payments, sales and marketing issues and good manufacturing practices, as well in federal and state lawsuits challenging AWP drug pricing.
- Lead counsel to Boehringer Ingelheim in the Canadian import antitrust litigation.
- Represented Procter & Gamble Pharmaceuticals, Inc. in a California antitrust and unfair competition case challenging a contract authorizing the sale of an "authorized generic" version of P&GP's Macrobid.
- National co-coordinating counsel for Hoffmann-La Roche Inc. and Roche Laboratories Inc. in Accutane products liability cases pending in Federal MDL, New Jersey Mass Tort proceeding, and cases nationwide alleging that Accutane causes depression, psychosis, suicide, violence, and other psychiatric side effects. Covington also managed all political aspects of this controversy. Drawing on the substantial experience of our lawyers in dealing with the House Energy and Commerce Committee, we worked closely with the committee staff over an 18-month period to provide documents and other requested information. The Committee ultimately held a day-long hearing in December 2002, and we prepared company executives to testify, including Roche's President and CEO.
- Lead counsel to Purdue Pharma in OxyContin® antitrust and consumer protection class actions.
Accolades
- PLC Cross-Border Super League
- Ranked 1st in the Life Sciences Regulatory Super League (2004-2011)
- Ranked 1st in the Life Sciences Industry Super League (2005-2009)
- PLC Life Sciences, Which Law Firm? (2006-2009)
- Leading: Government Enforcement & Investigations, USA
- Highly Recommended: Product Liability, England
- Recommended: Product Liability, USA
|
|